Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
27 August 2010
IN THIS ISSUE
ABPI code breached
Open-source R&D
Vaccine market growth
Health emergency supplies
GSK breaches ABPI code of conduct
GlaxoSmithKline Consumer Healthcare, Cephalon UK Ltd and ProStraken Group plc have been named and publicly shamed for breaching the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice. More...
 
Pharma’s future: open-source R&D
The future of pharmaceutical R&D may lie in open-source research, with key data being made available to a number of people, including college students and university researchers, in an open and collaborative process. More...
 
Strong growth predicted for global vaccine market
The market for vaccines is increasing quickly and major pharmaceutical companies such as Pfizer and GlaxoSmithKline are competing for a greater share of it. More...
 
HHS recommends improvements to US medical and vaccine preparedness
The US Department of Health and Human Services (HHS) Secretary has released an examination of the federal government’s system to produce medical countermeasures, or medications, vaccines, equipment and supplies needed for a health emergency. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
Journey to the center of the mind
J&J plans to improve manufacturing quality
Pharma accused of misleading regulators
More blog posts

Biosimilars articles
The changing landscape for biosimilars
What is hindering the uptake of biosimilars?
True biosimilars do not offer a compelling business case
Read more latest articles

Upcoming events
2010 PDA/FDA Joint Regulatory Conference (13–16 September | USA)
DigiPharm Europe 2010 (28 September–1 October | UK)
BioBusiness Network (29–30 September | Switzerland)
More events

Product Profile
Center for Professional Advancement
Access Training You Need Now
With over 100 Live and On-Demand Online Training courses, and nearly 300 instructor led courses to choose from - CfPA's Accredited courses can ensure you receive the skills and knowledge that will make a difference in your career. Register now for: IQ/OQ/PQ Dublin 10 Feb, Root Cause Investigation for CAPA Dublin 24 Feb, or Effective FDA Submissions 12 Feb Online.

Read more...

Product Profile
Shimadzu
LC-30A Nexera - the cleanest and fastest UHPLC ever to date.
Shimadzu's new LC-30A Nexera is unsurpassed in high-speed and high-resolution analysis and productivity.  It meets the needs of the most demanding markets such as pharmaceutical and the food industry.

Read more...

Product Profile
Vetter
Flexible options in final assembly and secondary packaging
Vetter's state-of-the-art secondary packaging facility offers customers the option of one-stop shopping in the drug production process.

Read more...




Survey
Do you agree with the US Federal Trade Commission that pay-to-delay deals are anticompetitive?
Yes 84%
No 16%

This week we would like to know...

Does your company currently use single-use technology for pharma/biopharma manufacturing?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom